Understanding how HIV-related Kaposi Sarcoma progresses in patients receiving local treatment in Malawi and South Africa
Project 2: Clinical and molecular determinants of HIV-associated Kaposi Sarcoma progression under local standard-of-care therapy in Malawi and South Africa
This study is looking at how different factors affect the growth of Kaposi Sarcoma in people with HIV in Malawi and South Africa, with the goal of finding better treatments and ways to predict how the disease will progress.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Univ of North Carolina Chapel Hill NIH-funded |
| Lab location | 1 site (Chapel Hill, United States) |
| Project ID | NIH-10891545 on NIH RePORTER |
What this research studies
This research investigates the clinical and molecular factors that influence the progression of Kaposi Sarcoma in patients living with HIV who are receiving standard care in Malawi and South Africa. The project aims to establish a collaborative research center that focuses on HIV-associated malignancies, leveraging expertise from institutions in the U.S. and Africa. By analyzing patient data and biological samples, the research seeks to identify new treatment options and prognostic biomarkers that could improve patient outcomes. The study builds on previous clinical trials and aims to provide insights into effective therapies for this common cancer in Sub-Saharan Africa.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals living with HIV who have been diagnosed with Kaposi Sarcoma and are receiving treatment in Malawi or South Africa.
Not a fit: Patients who do not have HIV or who are not diagnosed with Kaposi Sarcoma may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies and better prognostic tools for patients with HIV-associated Kaposi Sarcoma.
How similar studies have performed: Previous research has shown success in identifying effective treatments for HIV-associated malignancies, making this approach promising.
Where this research is happening
Chapel Hill, United States
- Univ of North Carolina Chapel Hill — Chapel Hill, United States (Active)
Researchers
- Principal investigator: Dittmer, Dirk P — Univ of North Carolina Chapel Hill
- Study coordinator: Dittmer, Dirk P
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.